Trending Now
Tellurian Inc (TELL) Advances Driftwood LNG Project Amid Financial Flexibility Moves,...
Tellurian Inc. (TELL), closed its last session at $0.8650, matching its opening price for the day. Amidst active trading, today, bids soared...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
AbCellera Biologics Inc (NASDAQ:ABCL) Expands Collaboration Accord With Gilead Sciences, Inc...
AbCellera Biologics Inc (NASDAQ:ABCL) signed an extended collaboration deal with Gilead Sciences, Inc (NASDAQ:GILD) for multi-body antibody discovery. The deal also provides access to...
MAKE IT MODERN
LATEST REVIEWS
Pre-Market SPY moves up over 300
Today we are seeing a rally over the weekend in our markets as well as in the markets in Europe and in Asia....
MAKE IT MODERN
PERFORMANCE TRAINING
The Future of Cannabis (APHA, TCNNF, SGMD, CURLF, TLRY)
As the Cannabis sector gets traction during what appears to be a new and emerging bull market in the space, it makes sense for...
Ligand OmniAb® Partner Immunovant Inc. (NASDAQ:IMVT) Says the Phase 2a Trial of IMVT-1401 in...
A Phase 2a study of OmniAb-derived IMVT-1401 being carried out by Ligand OmniAb® Partner Immunovant Inc. (NASDAQ:IMVT) has delivered positive topline results. The study,...
Omeros Corporation (NASDAQ:OMER) Publishes Final Safety And Efficacy Data From Narsoplimab Stem Cell Transplantation...
Omeros Corporation (NASDAQ:OMER) recently disclosed its comprehensive final findings of its clinical trial evaluating narsoplimab’s performance in hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA).
Narsoplimab...
Why the Latest GCGX Move Could Spark Fresh Interest
Global Consortium Inc. (OTCMKTS:GCGX) is making waves again, with shares pushing off recent basing lows to kick off the holiday-shortened week. The...
TRACON Pharmaceuticals (NASDAQ:TCON): A Promising Contender in Cancer Therapeutics
As the biopharmaceutical landscape continues to evolve, TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a San Diego-based clinical-stage biopharmaceutical company, has emerged as...
MAKE IT MODERN
